Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:28 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3Active, not recruitingINTERVENTIONAL

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

ClinicalTrials.gov · NCT07284979 · Registry updated: 2026-10-06

Condition / research focus: Obesity
Sponsor: Kailera
Countries with listed sites: Australia · Bulgaria · Poland · United Kingdom · United States
Registry dates and results: Start: 2025-12-30. Completion: 2028-04 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ribupatide (drug) — also listed as: KAI-9531
Semaglutide (drug) — also listed as: Wegovy
Placebo (drug)

Where the study takes place — 60 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Kailera Clinical Site
Glendale, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Phoenix, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Little Rock, Arkansas, United States
Site recruitment: Not reported
Kailera Clinical Site
Northridge, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Oceanside, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Hamden, Connecticut, United States
Site recruitment: Not reported
Kailera Clinical Site
Stamford, Connecticut, United States
Site recruitment: Not reported
Kailera Clinical Site
Orange City, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Albany, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Chicago, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Skokie, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Newton, Kansas, United States
Site recruitment: Not reported
Kailera Clinical Site
Shreveport, Louisiana, United States
Site recruitment: Not reported
Kailera Clinical Site
Farmington Hills, Michigan, United States
Site recruitment: Not reported
Kailera Clinical Site
Missoula, Montana, United States
Site recruitment: Not reported
Kailera Clinical Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Kailera Clinical Site
Albany, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
Morehead City, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Morrisville, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Norman, Oklahoma, United States
Site recruitment: Not reported
Kailera Clinical Site
East Greenwich, Rhode Island, United States
Site recruitment: Not reported
Kailera Clinical Site
North Charleston, South Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Spartanburg, South Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Brownsville, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site #1
San Antonio, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site #2
San Antonio, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Manassas, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
Richmond, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
Bruce, Australian Capital Territory, Australia
Site recruitment: Not reported
Kailera Clinical Site
Blacktown, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Kanwal, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Herston, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Morayfield, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
South Brisbane, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Camberwell, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
Pleven, Pleven Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Plovdiv, Plovdiv Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Varna, Varna Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Montana, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Stara Zagora, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Krakow, Lesser Poland Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Warsaw, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Gdynia, Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Chorzów, Silesian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Bydgoszcz, Poland
Site recruitment: Not reported
Kailera Clinical Site
Gdynia, Poland
Site recruitment: Not reported
Kailera Clinical Site
Wroclaw, Poland
Site recruitment: Not reported
Kailera Clinical Site
Kielce, Świętokrzyskie Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Exeter, Devon, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Torquay, Devon, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Weymouth, Dorset, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Glasgow, Glasgow City, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
London, Greater London, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
London, Greater London, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Leicester, Leicestershire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Rotherham, South Yorkshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3Active, not recruitingINTERVENTIONAL

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

ClinicalTrials.gov · NCT07284901 · Registry updated: 2026-10-06

Condition / research focus: Obesity With Diabetes; Overweight With Diabetes
Sponsor: Kailera
Countries with listed sites: Argentina · Australia · Bulgaria · Czechia · Germany · New Zealand · Poland · Puerto Rico · Spain · United Kingdom · United States
Registry dates and results: Start: 2026-01-12. Completion: 2028-04-24 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ribupatide (drug) — also listed as: KAI-9531
Placebo (drug)

Where the study takes place — 173 listed sites

Kailera Clinical Site
Cullman, Alabama, United States
Site recruitment: Not reported
Kailera Clinical Site
Phoenix, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Sun City, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Little Rock, Arkansas, United States
Site recruitment: Not reported
Kailera Clinical Site
Escondido, California, United States
Site recruitment: Not reported
Kailera Clinical Site
La Mesa, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Montclair, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Northridge, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Oceanside, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Toluca Lake, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Stamford, Connecticut, United States
Site recruitment: Not reported
Kailera Clinical Site
Bradenton, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Hollywood, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Jupiter, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Miami, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Miami Lakes, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Orange City, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Orlando, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Orlando, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
The Villages, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Decatur, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Lilburn, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Marietta, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Riverdale, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Skokie, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Springfield, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Newton, Kansas, United States
Site recruitment: Not reported
Kailera Clinical Site
Shreveport, Louisiana, United States
Site recruitment: Not reported
Kailera Clinical Site
Annapolis, Maryland, United States
Site recruitment: Not reported
Kailera Clinical Site
Columbia, Maryland, United States
Site recruitment: Not reported
Kailera Clinical Site
Boston, Massachusetts, United States
Site recruitment: Not reported
Kailera Clinical Site
Farmington Hills, Michigan, United States
Site recruitment: Not reported
Kailera Clinical Site
Missoula, Montana, United States
Site recruitment: Not reported
Kailera Clinical Site
Lincoln, Nebraska, United States
Site recruitment: Not reported
Kailera Clinical Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Kailera Clinical Site
Albany, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
Laurelton, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
New York, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
Greensboro, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Monroe, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site #1
Morehead City, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site #2
Morehead City, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Morrisville, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Cleveland, Ohio, United States
Site recruitment: Not reported
Kailera Clinical Site
Chickasha, Oklahoma, United States
Site recruitment: Not reported
Kailera Clinical Site
East Greenwich, Rhode Island, United States
Site recruitment: Not reported
Kailera Clinical Site
Spartanburg, South Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Kailera Clinical Site
Memphis, Tennessee, United States
Site recruitment: Not reported
Kailera Clinical Site
Amarillo, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Brownsville, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
DeSoto, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
El Paso, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Farmers Branch, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Kingwood, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Plano, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Tomball, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Pleasant View, Utah, United States
Site recruitment: Not reported
Kailera Clinical Site
Salt Lake City, Utah, United States
Site recruitment: Not reported
Kailera Clinical Site
Manassas, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
Richmond, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
Seattle, Washington, United States
Site recruitment: Not reported
Kailera Clinical Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
La Plata, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Mar del Plata, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
San Nicolás de los Arroyos, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Zárate, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Godoy Cruz, Mendoza Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #3
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #4
Rosario, Sante Fe, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Córdoba, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Córdoba, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Bruce, Australian Capital Territory, Australia
Site recruitment: Not reported
Kailera Clinical Site
Blacktown, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Charlestown, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Kanwal, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Leichhardt, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Penrith, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Wollongong, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Herston, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Morayfield, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Camberwell, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
Melbourne, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
South Brisbane, Australia
Site recruitment: Not reported
Kailera Clinical Site
Kyustendil, Kyustendil Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Pleven, Pleven Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Plovdiv, Plovdiv Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Rousse, Ruse Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Stara Zagora, Stara Zagora Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Varna, Varna Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Montana, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Brandýs nad Labem, Central Bohemia, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Náchod, Hradec Králové Region, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Trutnov, Hradec Králové Region, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Bohnice, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Brno, South Moravian, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Holešov, Zlín, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Hodonín, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Olomouc, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Pardubice, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Uherské Hradiště, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Tübingen, Baden-Wurttemberg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Falkensee, Brandenburg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Cologne, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site #1
Essen, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site #2
Essen, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site
Oldenburg in Holstein, Schleswig-Holstein, Germany
Site recruitment: Not reported
Kailera Clinical Site
Schwerin, Germany
Site recruitment: Not reported
Kailera Clinical Site
Grafton, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
New Lynn, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Silverdale, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Takapuna, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Nawton, Hamilton, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Hastings, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Nelson, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Torun, Kuyavian-Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Krakow, Lesser Poland Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Lublin, Lublin Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Siedlce, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Warsaw, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Bialystok, Podlaskie Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site #1
Gdynia, Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site #2
Gdynia, Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Chorzów, Silesian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Krakow, Poland
Site recruitment: Not reported
Kailera Clinical Site
Warsaw, Poland
Site recruitment: Not reported
Kailera Clinical Site
Skierniewice, Łódź Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Kielce, Świętokrzyskie Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site #1
Bayamón, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site #2
Bayamón, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
Ponce, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
San Juan, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
San Juan, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
Vega Baja, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
Ferrol, A Coruna, Spain
Site recruitment: Not reported
Kailera Clinical Site
Seville, Andalusia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Villamartín, Cadiz, Spain
Site recruitment: Not reported
Kailera Clinical Site
Barcelona, Catalonia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Oviedo, Principality of Asturias, Spain
Site recruitment: Not reported
Kailera Clinical Site
Castilleja de la Cuesta, Sevilla, Spain
Site recruitment: Not reported
Kailera Clinical Site
Madrid, Spain
Site recruitment: Not reported
Kailera Clinical Site
Seville, Spain
Site recruitment: Not reported
Kailera Clinical Site
Seville, Spain
Site recruitment: Not reported
Kailera Clinical Site
Valencia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Truro, Cornwall, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Plymouth, Devon, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Bournemouth, Dorset, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Hull, East Yorkshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Glasgow, Glasgow City, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
London, Greater London, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Stevenage, Hertfordshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Leicester, Leicestershire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Nottingham, Nottinghamshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Yate, South Gloucestershire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Newcastle upon Tyne, Tyne and Wear, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Bradford, West Yorkshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Manchester, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3Active, not recruitingINTERVENTIONAL

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

ClinicalTrials.gov · NCT07284875 · Registry updated: 2026-10-06

Condition / research focus: Obesity; Overweight
Sponsor: Kailera
Countries with listed sites: Argentina · Australia · Bulgaria · Czechia · Germany · New Zealand · Poland · Spain · United Kingdom · United States
Registry dates and results: Start: 2025-12-18. Completion: 2028-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ribupatide (drug) — also listed as: KAI-9531
Placebo (drug)

Where the study takes place — 110 listed sites

Kailera Clinical Site
Anniston, Alabama, United States
Site recruitment: Not reported
Kailera Clinical Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Kailera Clinical Site
Cullman, Alabama, United States
Site recruitment: Not reported
Kailera Clinical Site
Sun City, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Escondido, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Toluca Lake, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Aurora, Colorado, United States
Site recruitment: Not reported
Kailera Clinical Site
Bridgeport, Connecticut, United States
Site recruitment: Not reported
Kailera Clinical Site
Jupiter, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Lilburn, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Springfield, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Columbia, Maryland, United States
Site recruitment: Not reported
Kailera Clinical Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Kailera Clinical Site
Rochester, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
Morehead City, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Chickasha, Oklahoma, United States
Site recruitment: Not reported
Kailera Clinical Site
Mauldin, South Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Kailera Clinical Site
Amarillo, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Bellaire, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
DeSoto, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Tomball, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Salt Lake City, Utah, United States
Site recruitment: Not reported
Kailera Clinical Site
Danville, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
La Plata, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
San Nicolás de los Arroyos, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
San Nicolás de los Arroyos, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
Buenos Aires, Buenos Aires F.D., Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
Buenos Aires, Buenos Aires F.D., Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina
Site recruitment: Not reported
Kailera Clinical Site
Godoy Cruz, Mendoza Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #3
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site
CABA, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Córdoba, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Charlestown, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Wollongong, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sippy Downs, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Norwood, South Australia, Australia
Site recruitment: Not reported
Kailera Clinical Site
Heidelberg Heights, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
Melbourne, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
Kyustendil, Kyustendil Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Pazardzhik, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Plovdiv, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Plovdiv, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site #1
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site #2
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site #3
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Varna, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Yambol, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Brandýs nad Labem, Central Bohemia, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Náchod, Hradec Králové Region, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Krnov, Moravian-Silesian Region, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Bohnice, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Brno, South Moravian, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Hodonín, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Olomouc, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Uherské Hradiště, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Tübingen, Baden-Wurttemberg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Falkensee, Brandenburg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Cologne, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site
Essen, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site
Dresden, Saxony, Germany
Site recruitment: Not reported
Kailera Clinical Site
Leipzig, Saxony, Germany
Site recruitment: Not reported
Kailera Clinical Site
Oldenburg in Holstein, Schleswig-Holstein, Germany
Site recruitment: Not reported
Kailera Clinical Site
Hamburg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Hamburg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Schwerin, Germany
Site recruitment: Not reported
Kailera Clinical Site
Grafton, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Silverdale, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Hamilton, Waikato Region, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Nelson, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Poznan, Greater Poland Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Torun, Kuyavian-Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Krakow, Lesser Poland Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Siedlce, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Warsaw, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Skierniewice, Poland
Site recruitment: Not reported
Kailera Clinical Site
Zamość, Poland
Site recruitment: Not reported
Kailera Clinical Site
Ferrol, A Coruna, Spain
Site recruitment: Not reported
Kailera Clinical Site
Seville, Andalusia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Villamartín, Cadiz, Spain
Site recruitment: Not reported
Kailera Clinical Site
Barcelona, Catalonia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Oviedo, Principality of Asturias, Spain
Site recruitment: Not reported
Kailera Clinical Site
Castilleja de la Cuesta, Sevilla, Spain
Site recruitment: Not reported
Kailera Clinical Site
Barcelona, Spain
Site recruitment: Not reported
Kailera Clinical Site
Madrid, Spain
Site recruitment: Not reported
Kailera Clinical Site
Valencia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Soham, Cambridgeshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Torpoint, Cornwall, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Hull, East Yorkshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Stevenage, Hertfordshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Leicester, Leicestershire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Nottingham, Nottinghamshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Newcastle upon Tyne, Tyne and Wear, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Bradford, West Yorkshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Hounslow, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
London, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Manchester, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

ClinicalTrials.gov · NCT07218445 · Registry updated: 2026-10-06

Condition / research focus: Obesity; Menopause Hot Flashes
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2026-04-08. Completion: 2027-09-18 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Mayo Clinic in Florida
Jacksonville, Florida, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

ClinicalTrials.gov · NCT07224880 · Registry updated: 2026-10-05

Condition / research focus: glp1 Agonist; Gene Expression; Skin Laxity
Sponsor: Cytrellis Biosystems, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2025-10-14. Completion: 2026-08-21 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ellacor (device) — also listed as: micro-coring, dermal micro-coring

Where the study takes place — 1 listed sites

Tri Valley Plastic Surgery
Dublin, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

ClinicalTrials.gov · NCT06706284 · Registry updated: 2026-10-05

Condition / research focus: Spinal Cord Injuries; Type 2 Diabetes
Sponsor: Marzieh Salehi
Countries with listed sites: United States
Registry dates and results: Start: 2025-04-11. Completion: 2029-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Semaglutide Injectable Product (drug) — also listed as: Ozempic
Placebo (other) — also listed as: Saline solution

Where the study takes place — 2 listed sites

University Health - Texas Diabetic Institute
San Antonio, Texas, United States
Site recruitment: Recruiting
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

ClinicalTrials.gov · NCT06058585 · Registry updated: 2026-10-05

Condition / research focus: Chronic Kidney Diseases
Sponsor: The George Institute
Countries with listed sites: Australia · India · New Zealand · Spain · Sri Lanka
Registry dates and results: Start: 2024-09-04. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Finerenone (drug) — also listed as: BAY94-8862
Placebo Finerenone (drug)
Semaglutide (drug)
Placebo semaglutide (drug)

Where the study takes place — 51 listed sites

The Canberra Hospital
Garran, Australian Capital Territory, Australia
Site recruitment: Recruiting
Nepean Blue Mountains Local Health District
Kingswood, New South Wales, Australia
Site recruitment: Recruiting
St George Hospital
Kogarah, New South Wales, Australia
Site recruitment: Recruiting
John Hunter Hospital
New Lambton Heights, New South Wales, Australia
Site recruitment: Recruiting
Westmead Hospital
Westmead, New South Wales, Australia
Site recruitment: Recruiting
Sunshine Coast Hospital and Health Service
Birtinya, Queensland, Australia
Site recruitment: Recruiting
Townsville University Hospital
Douglas, Queensland, Australia
Site recruitment: Recruiting
West Moreton Hospital & Health Service
Ipswich, Queensland, Australia
Site recruitment: Recruiting
Gold Coast Hospital and Health Service
Southport, Queensland, Australia
Site recruitment: Recruiting
Royal Adelaide
Adelaide, South Australia, Australia
Site recruitment: Recruiting
Lyell McEwin Hospital
Elizabeth Vale, South Australia, Australia
Site recruitment: Recruiting
Austin Health
Heidelberg, Victoria, Australia
Site recruitment: Recruiting
South Metropolitan Health Service, Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Site recruitment: Recruiting
Gitam Institute of Medical Sciences and Research
Visakhapatnam, Andhra Pradesh, India
Site recruitment: Recruiting
Patna Medical College and Hospital
Patna, Bihar, India
Site recruitment: Recruiting
DKS Super Speciality Hospital, Raipur
Raipur, Chhattisgarh, India
Site recruitment: Recruiting
Mysore Medical College
Dehradun, Dehradun, India
Site recruitment: Recruiting
GCS Medical College, Hospital & Research Centre
Ahmedabad, Gujarat, India
Site recruitment: Recruiting
Aman Hospital & Research Center Vadodara
Vadodara, Gujarat, India
Site recruitment: Recruiting
Father Muller Medical College Hospital
Mangaluru, Karnataka, India
Site recruitment: Recruiting
Dr Moopen's Medical College
Meppādi, Kerala, India
Site recruitment: Recruiting
CARE-CHL Hospital
Indore, Madhya Pradesh, India
Site recruitment: Recruiting
Medway Hospital
Chennai, Tamil Nadu, India
Site recruitment: Recruiting
Yashoda Hospital Hitec City
Hyderabad, Telangana, India
Site recruitment: Recruiting
Apollo Hospitals
Hyderabad, Telangana, India
Site recruitment: Recruiting
Charak Hospital and Research Centre
Lucknow, Uttar Pradesh, India
Site recruitment: Recruiting
Shri Guru Ram Rai Medical College and Shri Mahant Indiresh Hospital
Dehradun, Uttarakhand, India
Site recruitment: Recruiting
Fortis Hospital
Kolkata, West Bengal, India
Site recruitment: Recruiting
North Bengal Medical College & Hospital
Siliguri, West Bengal, India
Site recruitment: Recruiting
Max Superspeciality Hospital, Dehradun
Dehradun, India
Site recruitment: Not yet recruiting
Max Superspecialty Hospital, Ghaziabad
Ghaziabad, India
Site recruitment: Recruiting
Aarupadai Veedu Medical College & Hospital (AVMCH), Puducherry
Puducherry, India
Site recruitment: Recruiting
Health New Zealand, Te Whatu Ora Te Matau a Maui, Hawke's Bay Hospital
Hastings, Hawkes Bay, New Zealand
Site recruitment: Recruiting
Health New Zealand, Te Whatu Ora Waitemata, North Shore Hospital
Auckland, New Zealand
Site recruitment: Recruiting
Auckland City Hospital
Auckland, New Zealand
Site recruitment: Recruiting
Aotearoa Clinical Trials Trust, Middlemore Hospital
Auckland, New Zealand
Site recruitment: Recruiting
201 Great King Street, Central Dunedin, Dunedin 9016, New Zealand
Dunedin, New Zealand
Site recruitment: Recruiting
Midcentral - Palmerston North Hospital
Palmerston North, New Zealand
Site recruitment: Recruiting
Private Bag 9742 Maunu Road, Horahora, Whangārei 0148, New Zealand
Whangarei, New Zealand
Site recruitment: Recruiting
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain
Site recruitment: Active, not recruiting
Vall d'Hebron University Hospital
Horta-Guinardó, Barcelona, Spain
Site recruitment: Recruiting
Hospital Clinico Universitario València (INCLIVA)
Valencia, Espana, Spain
Site recruitment: Recruiting
Jaffna Teaching Hospital
Jaffna, Northern Province, Sri Lanka
Site recruitment: Recruiting
National Nephrology Specialized Hospital
Colombo, Polonnaruwa, Sri Lanka
Site recruitment: Recruiting
University Hospital, Kotelawala Defence University
Dehiwala, Western Province, Sri Lanka
Site recruitment: Recruiting
National Hospital of Sri Lanka
Colombo, Sri Lanka
Site recruitment: Recruiting
Kandy National Hospital
Kandy, Sri Lanka
Site recruitment: Recruiting
Kurunegala Teaching Hospital
Kurunegala, Sri Lanka
Site recruitment: Recruiting
Sri Jayewardenepura General Hospital
Nugegoda, Sri Lanka
Site recruitment: Recruiting
Peradeniya Teaching Hospital
Peradeniya, Sri Lanka
Site recruitment: Recruiting
Colombo North Teaching Hospital
Ragama, Sri Lanka
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1RecruitingINTERVENTIONAL

The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

ClinicalTrials.gov · NCT07212868 · Registry updated: 2026-10-05

Condition / research focus: Non-Diabetic
Sponsor: The University of Texas Health Science Center at San Antonio
Countries with listed sites: United States
Registry dates and results: Start: 2026-02-25. Completion: 2030-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

REMD-477 versus Placebo (drug)
Exogenous glucagon versus saline infusion (other)

Where the study takes place — 2 listed sites

Texas Diabetes Institute - University Health System
San Antonio, Texas, United States
Site recruitment: Recruiting
University of Texas San Antonio
San Antonio, Texas, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression

ClinicalTrials.gov · NCT07816744 · Registry updated: 2026-10-05

Condition / research focus: Atrial Fibrillation (AF); Obesity & Overweight
Sponsor: Axel Brandes
Countries with listed sites: Denmark
Registry dates and results: Start: 2026-10-01. Completion: 2030-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Structured weight loss program including behavioral support and optional meal re-placement or pharmacotherapy with Glucagon-like peptide-1 receptor agonists (GLP1-RA) (other)
Standard Care (in control arm) (other)

Where the study takes place — 2 listed sites

University Hospital Bispebjerg and Frederiksberg
Copenhagen, Denmark
Site recruitment: Not reported
Esbjerg Hospital - University Hospital of Southern Denmark
Esbjerg, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Active, not recruitingINTERVENTIONAL

GLP-1s to Enhance Lasting Optimal Weight

ClinicalTrials.gov · NCT06861439 · Registry updated: 2026-10-02

Condition / research focus: Obesity
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2025-07-07. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: Zepbound

Where the study takes place — 1 listed sites

Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

Tirzepatide in Obesity-Driven Endometrial Cancer

ClinicalTrials.gov · NCT07065552 · Registry updated: 2026-10-02

Condition / research focus: Endometrial Cancer; Obesity
Sponsor: UNC Lineberger Comprehensive Cancer Center
Countries with listed sites: United States
Registry dates and results: Start: 2026-04-27. Completion: 2028-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)

Where the study takes place — 1 listed sites

Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3Not yet recruitingINTERVENTIONAL

Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial

ClinicalTrials.gov · NCT07734792 · Registry updated: 2026-10-01

Condition / research focus: Acute Ischemic Stroke (AIS)
Sponsor: yifang zhu
Countries with listed sites: China
Registry dates and results: Start: 2026-09-20. Completion: 2028-07-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: Mounjaro
Standard Medical Care (SMC) (other)

Where the study takes place — 1 listed sites

The Second Afliated Hospital of SooChow University
Suzhou, Jiangsu, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1RecruitingINTERVENTIONAL

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

ClinicalTrials.gov · NCT07793929 · Registry updated: 2026-10-01

Condition / research focus: End Stage Renal Disease; Renal Impairment; Obesity; Overweight
Sponsor: Kailera
Countries with listed sites: United States
Registry dates and results: Start: 2026-09-08. Completion: 2028-02-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ribupatide (drug) — also listed as: KAI-9531

Where the study takes place — 2 listed sites

Kailera Clinical Site
Orlando, Florida, United States
Site recruitment: Recruiting
Kailera Clinical Site
San Antonio, Texas, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2Active, not recruitingINTERVENTIONAL

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

ClinicalTrials.gov · NCT05254314 · Registry updated: 2026-10-01

Condition / research focus: Asthma
Sponsor: Vanderbilt University Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2022-10-11. Completion: 2026-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Semaglutide Pen Injector 2.4mg weekly (drug) — also listed as: Wegovy
Placebo (other)

Where the study takes place — 1 listed sites

Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Combination Therapy for Alcohol Use Disorder

ClinicalTrials.gov · NCT07249554 · Registry updated: 2026-10-01

Condition / research focus: Alcohol Use Disorder
Sponsor: Johns Hopkins University
Countries with listed sites: United States
Registry dates and results: Start: 2026-11. Completion: 2028-09 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug)
Glucagon-Like Peptide-1 Agonist (GLP-1) (drug)
Naltrexone (oral tablets) (drug)

Where the study takes place — 1 listed sites

Ashley Addiction Treatment
Havre de Grace, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Active, not recruitingINTERVENTIONAL

Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

ClinicalTrials.gov · NCT06854614 · Registry updated: 2026-09-30

Condition / research focus: Obesity
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2025-03-01. Completion: 2028-04-28 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Comprehensive weight loss (other)
Enhanced lifestyle changes (other)
Tirzepatide (drug) — also listed as: Mounjaro
Naltrexone-Bupropion (drug) — also listed as: Contrave
Phentermine-Topiramate (drug) — also listed as: Qsymia
Semaglutide (Wegovy®) (drug)

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

ClinicalTrials.gov · NCT06603571 · Registry updated: 2026-09-29

Condition / research focus: Obesity; Overweight
Sponsor: Eli Lilly and Company
Countries with listed sites: Argentina · United States
Registry dates and results: Start: 2024-09-20. Completion: 2026-09-14 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LY3841136 (drug)
Tirzepatide (drug)
Placebo (drug)

Where the study takes place — 52 listed sites

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Chandler, Arizona, United States
Site recruitment: Not reported
HOPE Research Institute
Phoenix, Arizona, United States
Site recruitment: Not reported
Headlands Research - Scottsdale
Scottsdale, Arizona, United States
Site recruitment: Not reported
The Institute for Liver Health II dba Arizona Liver Health-Tucson
Tucson, Arizona, United States
Site recruitment: Not reported
NorCal Medical Research, Inc
Greenbrae, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Huntington Park
Huntington Park, California, United States
Site recruitment: Not reported
Peninsula Research Associates
Rolling Hills Estates, California, United States
Site recruitment: Not reported
Diablo Clinical Research, Inc.
Walnut Creek, California, United States
Site recruitment: Not reported
Stamford Therapeutics Consortium
Stamford, Connecticut, United States
Site recruitment: Not reported
Northeast Research Institute (NERI)
Fleming Island, Florida, United States
Site recruitment: Not reported
Indago Research & Health Center, Inc
Hialeah, Florida, United States
Site recruitment: Not reported
New Horizon Research Center
Miami, Florida, United States
Site recruitment: Not reported
Suncoast Clinical Research, Inc.
New Port Richey, Florida, United States
Site recruitment: Not reported
Charter Research - Winter Park
Orlando, Florida, United States
Site recruitment: Not reported
Charter Research - Lady Lake
The Villages, Florida, United States
Site recruitment: Not reported
Medical Research Partners
Ammon, Idaho, United States
Site recruitment: Not reported
Great Lakes Clinical Trials - Andersonville
Chicago, Illinois, United States
Site recruitment: Not reported
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois, United States
Site recruitment: Not reported
NorthShore University Health System
Skokie, Illinois, United States
Site recruitment: Not reported
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, United States
Site recruitment: Not reported
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, United States
Site recruitment: Not reported
Knownwell
Needham, Massachusetts, United States
Site recruitment: Not reported
Lucida Clinical Trials
New Bedford, Massachusetts, United States
Site recruitment: Not reported
Headlands Research - Detroit
Southfield, Michigan, United States
Site recruitment: Not reported
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan, United States
Site recruitment: Not reported
StudyMetrix Research
City of Saint Peters, Missouri, United States
Site recruitment: Not reported
Clinvest Headlands Llc
Springfield, Missouri, United States
Site recruitment: Not reported
Las Vegas Medical Research
Las Vegas, Nevada, United States
Site recruitment: Not reported
Dent Neurologic Institute
Amherst, New York, United States
Site recruitment: Not reported
Velocity Clinical Research, Syracuse
East Syracuse, New York, United States
Site recruitment: Not reported
North Suffolk Neurology
Port Jefferson Station, New York, United States
Site recruitment: Not reported
Rochester Clinical Research, LLC
Rochester, New York, United States
Site recruitment: Not reported
Medication Management
Greensboro, North Carolina, United States
Site recruitment: Not reported
Monroe Biomedical Research
Monroe, North Carolina, United States
Site recruitment: Not reported
Lucas Research, Inc
Morehead City, North Carolina, United States
Site recruitment: Not reported
Lucas Research, Inc.
New Bern, North Carolina, United States
Site recruitment: Not reported
CTI Clinical Research Center
Cincinnati, Ohio, United States
Site recruitment: Not reported
Tribe Clinical Research, LLC
Greenville, South Carolina, United States
Site recruitment: Not reported
Quality Medical Research
Nashville, Tennessee, United States
Site recruitment: Not reported
IMA Clinical Research Austin
Austin, Texas, United States
Site recruitment: Not reported
Velocity Clinical Research, Dallas
Dallas, Texas, United States
Site recruitment: Not reported
FutureSearch Trials of Dallas
Dallas, Texas, United States
Site recruitment: Not reported
PlanIt Research, PLLC
Houston, Texas, United States
Site recruitment: Not reported
Tekton Research - Fredericksburg Road
San Antonio, Texas, United States
Site recruitment: Not reported
Endeavor Clinical Trials
San Antonio, Texas, United States
Site recruitment: Not reported
Texas Valley Clinical Research
Weslaco, Texas, United States
Site recruitment: Not reported
Spectrum Medical, Inc.
Danville, Virginia, United States
Site recruitment: Not reported
Central Washington Health Services Association d/b/a Confluence Health
Wenatchee, Washington, United States
Site recruitment: Not reported
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, Argentina
Site recruitment: Not reported
Centro Médico Viamonte
Buenos Aires, Argentina
Site recruitment: Not reported
Consultorio de Investigación Clínica EMO SRL
Buenos Aires, Argentina
Site recruitment: Not reported
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, Argentina
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study

ClinicalTrials.gov · NCT07846956 · Registry updated: 2026-09-29

Condition / research focus: Non-arteritic Anterior Ischemic Optic Neuropathy Obesity; Obesity
Sponsor: Istanbul Saglik Bilimleri University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2026-09-21. Completion: 2026-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GLP-1 Receptor Agonist Therapy (drug)

Where the study takes place — 1 listed sites

Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

ClinicalTrials.gov · NCT07527910 · Registry updated: 2026-09-29

Condition / research focus: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sponsor: Regeneron Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2026-05-22. Completion: 2030-03-15 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ALN-PNP (drug)
Tirzepatide (drug) — also listed as: Zepbound®
Placebo (drug)

Where the study takes place — 9 listed sites

Arizona Liver Health - Tucson
Tucson, Arizona, United States
Site recruitment: Recruiting
Southern California Research Center
Coronado, California, United States
Site recruitment: Recruiting
California Liver Research Institute
Pasadena, California, United States
Site recruitment: Recruiting
Health Awareness, Inc
Jupiter, Florida, United States
Site recruitment: Recruiting
Evolution Clinical Trials
Miami, Florida, United States
Site recruitment: Recruiting
Tandem Clinical Research, Plaza II
Metairie, Louisiana, United States
Site recruitment: Recruiting
American Research Corporation
Austin, Texas, United States
Site recruitment: Recruiting
Advanced Medical Trials
Georgetown, Texas, United States
Site recruitment: Recruiting
American Research Corporation at The Texas Liver Institute
San Antonio, Texas, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

ClinicalTrials.gov · NCT07078838 · Registry updated: 2026-09-28

Condition / research focus: Endometrial Cancer; Endometrial Intraepithelial Neoplasia; Grade 1 Endometrial Endometrioid Carcinoma
Sponsor: UNC Lineberger Comprehensive Cancer Center
Countries with listed sites: United States
Registry dates and results: Start: 2027-01. Completion: 2029-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)

Where the study takes place — 1 listed sites

Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:28 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3Active, not recruitingINTERVENTIONAL

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

ClinicalTrials.gov · NCT07284979 · Registry updated: 2026-10-06

Condition / research focus: Obesity
Sponsor: Kailera
Countries with listed sites: Australia · Bulgaria · Poland · United Kingdom · United States
Registry dates and results: Start: 2025-12-30. Completion: 2028-04 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ribupatide (drug) — also listed as: KAI-9531
Semaglutide (drug) — also listed as: Wegovy
Placebo (drug)

Where the study takes place — 60 listed sites

Kailera Clinical Site
Glendale, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Phoenix, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Little Rock, Arkansas, United States
Site recruitment: Not reported
Kailera Clinical Site
Northridge, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Oceanside, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Hamden, Connecticut, United States
Site recruitment: Not reported
Kailera Clinical Site
Stamford, Connecticut, United States
Site recruitment: Not reported
Kailera Clinical Site
Orange City, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Albany, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Chicago, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Skokie, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Newton, Kansas, United States
Site recruitment: Not reported
Kailera Clinical Site
Shreveport, Louisiana, United States
Site recruitment: Not reported
Kailera Clinical Site
Farmington Hills, Michigan, United States
Site recruitment: Not reported
Kailera Clinical Site
Missoula, Montana, United States
Site recruitment: Not reported
Kailera Clinical Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Kailera Clinical Site
Albany, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
Morehead City, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Morrisville, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Norman, Oklahoma, United States
Site recruitment: Not reported
Kailera Clinical Site
East Greenwich, Rhode Island, United States
Site recruitment: Not reported
Kailera Clinical Site
North Charleston, South Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Spartanburg, South Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Brownsville, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site #1
San Antonio, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site #2
San Antonio, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Manassas, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
Richmond, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
Bruce, Australian Capital Territory, Australia
Site recruitment: Not reported
Kailera Clinical Site
Blacktown, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Kanwal, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Herston, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Morayfield, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
South Brisbane, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Camberwell, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
Pleven, Pleven Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Plovdiv, Plovdiv Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Varna, Varna Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Montana, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Stara Zagora, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Krakow, Lesser Poland Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Warsaw, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Gdynia, Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Chorzów, Silesian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Bydgoszcz, Poland
Site recruitment: Not reported
Kailera Clinical Site
Gdynia, Poland
Site recruitment: Not reported
Kailera Clinical Site
Wroclaw, Poland
Site recruitment: Not reported
Kailera Clinical Site
Kielce, Świętokrzyskie Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Exeter, Devon, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Torquay, Devon, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Weymouth, Dorset, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Glasgow, Glasgow City, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
London, Greater London, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
London, Greater London, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Leicester, Leicestershire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Rotherham, South Yorkshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3Active, not recruitingINTERVENTIONAL

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

ClinicalTrials.gov · NCT07284901 · Registry updated: 2026-10-06

Condition / research focus: Obesity With Diabetes; Overweight With Diabetes
Sponsor: Kailera
Countries with listed sites: Argentina · Australia · Bulgaria · Czechia · Germany · New Zealand · Poland · Puerto Rico · Spain · United Kingdom · United States
Registry dates and results: Start: 2026-01-12. Completion: 2028-04-24 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ribupatide (drug) — also listed as: KAI-9531
Placebo (drug)

Where the study takes place — 173 listed sites

Kailera Clinical Site
Cullman, Alabama, United States
Site recruitment: Not reported
Kailera Clinical Site
Phoenix, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Sun City, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Little Rock, Arkansas, United States
Site recruitment: Not reported
Kailera Clinical Site
Escondido, California, United States
Site recruitment: Not reported
Kailera Clinical Site
La Mesa, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Montclair, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Northridge, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Oceanside, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Toluca Lake, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Stamford, Connecticut, United States
Site recruitment: Not reported
Kailera Clinical Site
Bradenton, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Hollywood, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Jupiter, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Miami, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Miami Lakes, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Orange City, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Orlando, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Orlando, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
The Villages, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Decatur, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Lilburn, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Marietta, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Riverdale, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Skokie, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Springfield, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Newton, Kansas, United States
Site recruitment: Not reported
Kailera Clinical Site
Shreveport, Louisiana, United States
Site recruitment: Not reported
Kailera Clinical Site
Annapolis, Maryland, United States
Site recruitment: Not reported
Kailera Clinical Site
Columbia, Maryland, United States
Site recruitment: Not reported
Kailera Clinical Site
Boston, Massachusetts, United States
Site recruitment: Not reported
Kailera Clinical Site
Farmington Hills, Michigan, United States
Site recruitment: Not reported
Kailera Clinical Site
Missoula, Montana, United States
Site recruitment: Not reported
Kailera Clinical Site
Lincoln, Nebraska, United States
Site recruitment: Not reported
Kailera Clinical Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Kailera Clinical Site
Albany, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
Laurelton, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
New York, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
Greensboro, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Monroe, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site #1
Morehead City, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site #2
Morehead City, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Morrisville, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Cleveland, Ohio, United States
Site recruitment: Not reported
Kailera Clinical Site
Chickasha, Oklahoma, United States
Site recruitment: Not reported
Kailera Clinical Site
East Greenwich, Rhode Island, United States
Site recruitment: Not reported
Kailera Clinical Site
Spartanburg, South Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Kailera Clinical Site
Memphis, Tennessee, United States
Site recruitment: Not reported
Kailera Clinical Site
Amarillo, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Brownsville, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
DeSoto, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
El Paso, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Farmers Branch, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Kingwood, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Plano, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Tomball, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Pleasant View, Utah, United States
Site recruitment: Not reported
Kailera Clinical Site
Salt Lake City, Utah, United States
Site recruitment: Not reported
Kailera Clinical Site
Manassas, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
Richmond, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
Seattle, Washington, United States
Site recruitment: Not reported
Kailera Clinical Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
La Plata, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Mar del Plata, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
San Nicolás de los Arroyos, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Zárate, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Godoy Cruz, Mendoza Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #3
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #4
Rosario, Sante Fe, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Córdoba, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Córdoba, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Bruce, Australian Capital Territory, Australia
Site recruitment: Not reported
Kailera Clinical Site
Blacktown, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Charlestown, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Kanwal, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Leichhardt, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Penrith, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Wollongong, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Herston, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Morayfield, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Camberwell, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
Melbourne, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
South Brisbane, Australia
Site recruitment: Not reported
Kailera Clinical Site
Kyustendil, Kyustendil Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Pleven, Pleven Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Plovdiv, Plovdiv Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Rousse, Ruse Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Stara Zagora, Stara Zagora Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Varna, Varna Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Montana, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Brandýs nad Labem, Central Bohemia, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Náchod, Hradec Králové Region, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Trutnov, Hradec Králové Region, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Bohnice, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Brno, South Moravian, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Holešov, Zlín, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Hodonín, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Olomouc, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Pardubice, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Uherské Hradiště, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Tübingen, Baden-Wurttemberg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Falkensee, Brandenburg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Cologne, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site #1
Essen, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site #2
Essen, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site
Oldenburg in Holstein, Schleswig-Holstein, Germany
Site recruitment: Not reported
Kailera Clinical Site
Schwerin, Germany
Site recruitment: Not reported
Kailera Clinical Site
Grafton, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
New Lynn, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Silverdale, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Takapuna, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Nawton, Hamilton, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Hastings, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Nelson, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Torun, Kuyavian-Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Krakow, Lesser Poland Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Lublin, Lublin Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Siedlce, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Warsaw, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Bialystok, Podlaskie Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site #1
Gdynia, Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site #2
Gdynia, Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Chorzów, Silesian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Krakow, Poland
Site recruitment: Not reported
Kailera Clinical Site
Warsaw, Poland
Site recruitment: Not reported
Kailera Clinical Site
Skierniewice, Łódź Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Kielce, Świętokrzyskie Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site #1
Bayamón, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site #2
Bayamón, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
Ponce, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
San Juan, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
San Juan, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
Vega Baja, Puerto Rico
Site recruitment: Not reported
Kailera Clinical Site
Ferrol, A Coruna, Spain
Site recruitment: Not reported
Kailera Clinical Site
Seville, Andalusia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Villamartín, Cadiz, Spain
Site recruitment: Not reported
Kailera Clinical Site
Barcelona, Catalonia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Oviedo, Principality of Asturias, Spain
Site recruitment: Not reported
Kailera Clinical Site
Castilleja de la Cuesta, Sevilla, Spain
Site recruitment: Not reported
Kailera Clinical Site
Madrid, Spain
Site recruitment: Not reported
Kailera Clinical Site
Seville, Spain
Site recruitment: Not reported
Kailera Clinical Site
Seville, Spain
Site recruitment: Not reported
Kailera Clinical Site
Valencia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Truro, Cornwall, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Plymouth, Devon, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Bournemouth, Dorset, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Hull, East Yorkshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Glasgow, Glasgow City, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
London, Greater London, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Stevenage, Hertfordshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Leicester, Leicestershire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Nottingham, Nottinghamshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Yate, South Gloucestershire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Newcastle upon Tyne, Tyne and Wear, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Bradford, West Yorkshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Manchester, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3Active, not recruitingINTERVENTIONAL

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

ClinicalTrials.gov · NCT07284875 · Registry updated: 2026-10-06

Condition / research focus: Obesity; Overweight
Sponsor: Kailera
Countries with listed sites: Argentina · Australia · Bulgaria · Czechia · Germany · New Zealand · Poland · Spain · United Kingdom · United States
Registry dates and results: Start: 2025-12-18. Completion: 2028-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ribupatide (drug) — also listed as: KAI-9531
Placebo (drug)

Where the study takes place — 110 listed sites

Kailera Clinical Site
Anniston, Alabama, United States
Site recruitment: Not reported
Kailera Clinical Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Kailera Clinical Site
Cullman, Alabama, United States
Site recruitment: Not reported
Kailera Clinical Site
Sun City, Arizona, United States
Site recruitment: Not reported
Kailera Clinical Site
Escondido, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Toluca Lake, California, United States
Site recruitment: Not reported
Kailera Clinical Site
Aurora, Colorado, United States
Site recruitment: Not reported
Kailera Clinical Site
Bridgeport, Connecticut, United States
Site recruitment: Not reported
Kailera Clinical Site
Jupiter, Florida, United States
Site recruitment: Not reported
Kailera Clinical Site
Lilburn, Georgia, United States
Site recruitment: Not reported
Kailera Clinical Site
Springfield, Illinois, United States
Site recruitment: Not reported
Kailera Clinical Site
Columbia, Maryland, United States
Site recruitment: Not reported
Kailera Clinical Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Kailera Clinical Site
Rochester, New York, United States
Site recruitment: Not reported
Kailera Clinical Site
Morehead City, North Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Chickasha, Oklahoma, United States
Site recruitment: Not reported
Kailera Clinical Site
Mauldin, South Carolina, United States
Site recruitment: Not reported
Kailera Clinical Site
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Kailera Clinical Site
Amarillo, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Bellaire, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
DeSoto, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Tomball, Texas, United States
Site recruitment: Not reported
Kailera Clinical Site
Salt Lake City, Utah, United States
Site recruitment: Not reported
Kailera Clinical Site
Danville, Virginia, United States
Site recruitment: Not reported
Kailera Clinical Site
La Plata, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
San Nicolás de los Arroyos, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
San Nicolás de los Arroyos, Buenos Aires, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
Buenos Aires, Buenos Aires F.D., Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
Buenos Aires, Buenos Aires F.D., Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina
Site recruitment: Not reported
Kailera Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina
Site recruitment: Not reported
Kailera Clinical Site
Godoy Cruz, Mendoza Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #1
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #2
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site #3
Rosario, Santa Fe Province, Argentina
Site recruitment: Not reported
Kailera Clinical Site
CABA, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Córdoba, Argentina
Site recruitment: Not reported
Kailera Clinical Site
Charlestown, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sydney, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Wollongong, New South Wales, Australia
Site recruitment: Not reported
Kailera Clinical Site
Sippy Downs, Queensland, Australia
Site recruitment: Not reported
Kailera Clinical Site
Norwood, South Australia, Australia
Site recruitment: Not reported
Kailera Clinical Site
Heidelberg Heights, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
Melbourne, Victoria, Australia
Site recruitment: Not reported
Kailera Clinical Site
Kyustendil, Kyustendil Province, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Pazardzhik, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Plovdiv, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Plovdiv, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site #1
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site #2
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site #3
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Sofia, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Varna, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Yambol, Bulgaria
Site recruitment: Not reported
Kailera Clinical Site
Brandýs nad Labem, Central Bohemia, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Náchod, Hradec Králové Region, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Krnov, Moravian-Silesian Region, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Bohnice, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Brno, South Moravian, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Hodonín, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Olomouc, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Prague, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Uherské Hradiště, Czechia
Site recruitment: Not reported
Kailera Clinical Site
Tübingen, Baden-Wurttemberg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Falkensee, Brandenburg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Cologne, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site
Essen, North Rhine-Westphalia, Germany
Site recruitment: Not reported
Kailera Clinical Site
Dresden, Saxony, Germany
Site recruitment: Not reported
Kailera Clinical Site
Leipzig, Saxony, Germany
Site recruitment: Not reported
Kailera Clinical Site
Oldenburg in Holstein, Schleswig-Holstein, Germany
Site recruitment: Not reported
Kailera Clinical Site
Hamburg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Hamburg, Germany
Site recruitment: Not reported
Kailera Clinical Site
Schwerin, Germany
Site recruitment: Not reported
Kailera Clinical Site
Grafton, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Silverdale, Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Hamilton, Waikato Region, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Auckland, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Nelson, New Zealand
Site recruitment: Not reported
Kailera Clinical Site
Poznan, Greater Poland Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Torun, Kuyavian-Pomeranian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Krakow, Lesser Poland Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Siedlce, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Warsaw, Masovian Voivodeship, Poland
Site recruitment: Not reported
Kailera Clinical Site
Skierniewice, Poland
Site recruitment: Not reported
Kailera Clinical Site
Zamość, Poland
Site recruitment: Not reported
Kailera Clinical Site
Ferrol, A Coruna, Spain
Site recruitment: Not reported
Kailera Clinical Site
Seville, Andalusia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Villamartín, Cadiz, Spain
Site recruitment: Not reported
Kailera Clinical Site
Barcelona, Catalonia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Oviedo, Principality of Asturias, Spain
Site recruitment: Not reported
Kailera Clinical Site
Castilleja de la Cuesta, Sevilla, Spain
Site recruitment: Not reported
Kailera Clinical Site
Barcelona, Spain
Site recruitment: Not reported
Kailera Clinical Site
Madrid, Spain
Site recruitment: Not reported
Kailera Clinical Site
Valencia, Spain
Site recruitment: Not reported
Kailera Clinical Site
Soham, Cambridgeshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Torpoint, Cornwall, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Hull, East Yorkshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Stevenage, Hertfordshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Leicester, Leicestershire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Nottingham, Nottinghamshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Newcastle upon Tyne, Tyne and Wear, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Bradford, West Yorkshire, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Hounslow, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
London, United Kingdom
Site recruitment: Not reported
Kailera Clinical Site
Manchester, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With Obesity

ClinicalTrials.gov · NCT07218445 · Registry updated: 2026-10-06

Condition / research focus: Obesity; Menopause Hot Flashes
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2026-04-08. Completion: 2027-09-18 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Mayo Clinic in Florida
Jacksonville, Florida, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

ClinicalTrials.gov · NCT07224880 · Registry updated: 2026-10-05

Condition / research focus: glp1 Agonist; Gene Expression; Skin Laxity
Sponsor: Cytrellis Biosystems, Inc.
Countries with listed sites: United States
Registry dates and results: Start: 2025-10-14. Completion: 2026-08-21 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ellacor (device) — also listed as: micro-coring, dermal micro-coring

Where the study takes place — 1 listed sites

Tri Valley Plastic Surgery
Dublin, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes

ClinicalTrials.gov · NCT06706284 · Registry updated: 2026-10-05

Condition / research focus: Spinal Cord Injuries; Type 2 Diabetes
Sponsor: Marzieh Salehi
Countries with listed sites: United States
Registry dates and results: Start: 2025-04-11. Completion: 2029-03-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Semaglutide Injectable Product (drug) — also listed as: Ozempic
Placebo (other) — also listed as: Saline solution

Where the study takes place — 2 listed sites

University Health - Texas Diabetic Institute
San Antonio, Texas, United States
Site recruitment: Recruiting
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect

ClinicalTrials.gov · NCT06058585 · Registry updated: 2026-10-05

Condition / research focus: Chronic Kidney Diseases
Sponsor: The George Institute
Countries with listed sites: Australia · India · New Zealand · Spain · Sri Lanka
Registry dates and results: Start: 2024-09-04. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Finerenone (drug) — also listed as: BAY94-8862
Placebo Finerenone (drug)
Semaglutide (drug)
Placebo semaglutide (drug)

Where the study takes place — 51 listed sites

The Canberra Hospital
Garran, Australian Capital Territory, Australia
Site recruitment: Recruiting
Nepean Blue Mountains Local Health District
Kingswood, New South Wales, Australia
Site recruitment: Recruiting
St George Hospital
Kogarah, New South Wales, Australia
Site recruitment: Recruiting
John Hunter Hospital
New Lambton Heights, New South Wales, Australia
Site recruitment: Recruiting
Westmead Hospital
Westmead, New South Wales, Australia
Site recruitment: Recruiting
Sunshine Coast Hospital and Health Service
Birtinya, Queensland, Australia
Site recruitment: Recruiting
Townsville University Hospital
Douglas, Queensland, Australia
Site recruitment: Recruiting
West Moreton Hospital & Health Service
Ipswich, Queensland, Australia
Site recruitment: Recruiting
Gold Coast Hospital and Health Service
Southport, Queensland, Australia
Site recruitment: Recruiting
Royal Adelaide
Adelaide, South Australia, Australia
Site recruitment: Recruiting
Lyell McEwin Hospital
Elizabeth Vale, South Australia, Australia
Site recruitment: Recruiting
Austin Health
Heidelberg, Victoria, Australia
Site recruitment: Recruiting
South Metropolitan Health Service, Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Site recruitment: Recruiting
Gitam Institute of Medical Sciences and Research
Visakhapatnam, Andhra Pradesh, India
Site recruitment: Recruiting
Patna Medical College and Hospital
Patna, Bihar, India
Site recruitment: Recruiting
DKS Super Speciality Hospital, Raipur
Raipur, Chhattisgarh, India
Site recruitment: Recruiting
Mysore Medical College
Dehradun, Dehradun, India
Site recruitment: Recruiting
GCS Medical College, Hospital & Research Centre
Ahmedabad, Gujarat, India
Site recruitment: Recruiting
Aman Hospital & Research Center Vadodara
Vadodara, Gujarat, India
Site recruitment: Recruiting
Father Muller Medical College Hospital
Mangaluru, Karnataka, India
Site recruitment: Recruiting
Dr Moopen's Medical College
Meppādi, Kerala, India
Site recruitment: Recruiting
CARE-CHL Hospital
Indore, Madhya Pradesh, India
Site recruitment: Recruiting
Medway Hospital
Chennai, Tamil Nadu, India
Site recruitment: Recruiting
Yashoda Hospital Hitec City
Hyderabad, Telangana, India
Site recruitment: Recruiting
Apollo Hospitals
Hyderabad, Telangana, India
Site recruitment: Recruiting
Charak Hospital and Research Centre
Lucknow, Uttar Pradesh, India
Site recruitment: Recruiting
Shri Guru Ram Rai Medical College and Shri Mahant Indiresh Hospital
Dehradun, Uttarakhand, India
Site recruitment: Recruiting
Fortis Hospital
Kolkata, West Bengal, India
Site recruitment: Recruiting
North Bengal Medical College & Hospital
Siliguri, West Bengal, India
Site recruitment: Recruiting
Max Superspeciality Hospital, Dehradun
Dehradun, India
Site recruitment: Not yet recruiting
Max Superspecialty Hospital, Ghaziabad
Ghaziabad, India
Site recruitment: Recruiting
Aarupadai Veedu Medical College & Hospital (AVMCH), Puducherry
Puducherry, India
Site recruitment: Recruiting
Health New Zealand, Te Whatu Ora Te Matau a Maui, Hawke's Bay Hospital
Hastings, Hawkes Bay, New Zealand
Site recruitment: Recruiting
Health New Zealand, Te Whatu Ora Waitemata, North Shore Hospital
Auckland, New Zealand
Site recruitment: Recruiting
Auckland City Hospital
Auckland, New Zealand
Site recruitment: Recruiting
Aotearoa Clinical Trials Trust, Middlemore Hospital
Auckland, New Zealand
Site recruitment: Recruiting
201 Great King Street, Central Dunedin, Dunedin 9016, New Zealand
Dunedin, New Zealand
Site recruitment: Recruiting
Midcentral - Palmerston North Hospital
Palmerston North, New Zealand
Site recruitment: Recruiting
Private Bag 9742 Maunu Road, Horahora, Whangārei 0148, New Zealand
Whangarei, New Zealand
Site recruitment: Recruiting
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain
Site recruitment: Active, not recruiting
Vall d'Hebron University Hospital
Horta-Guinardó, Barcelona, Spain
Site recruitment: Recruiting
Hospital Clinico Universitario València (INCLIVA)
Valencia, Espana, Spain
Site recruitment: Recruiting
Jaffna Teaching Hospital
Jaffna, Northern Province, Sri Lanka
Site recruitment: Recruiting
National Nephrology Specialized Hospital
Colombo, Polonnaruwa, Sri Lanka
Site recruitment: Recruiting
University Hospital, Kotelawala Defence University
Dehiwala, Western Province, Sri Lanka
Site recruitment: Recruiting
National Hospital of Sri Lanka
Colombo, Sri Lanka
Site recruitment: Recruiting
Kandy National Hospital
Kandy, Sri Lanka
Site recruitment: Recruiting
Kurunegala Teaching Hospital
Kurunegala, Sri Lanka
Site recruitment: Recruiting
Sri Jayewardenepura General Hospital
Nugegoda, Sri Lanka
Site recruitment: Recruiting
Peradeniya Teaching Hospital
Peradeniya, Sri Lanka
Site recruitment: Recruiting
Colombo North Teaching Hospital
Ragama, Sri Lanka
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1RecruitingINTERVENTIONAL

The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery

ClinicalTrials.gov · NCT07212868 · Registry updated: 2026-10-05

Condition / research focus: Non-Diabetic
Sponsor: The University of Texas Health Science Center at San Antonio
Countries with listed sites: United States
Registry dates and results: Start: 2026-02-25. Completion: 2030-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

REMD-477 versus Placebo (drug)
Exogenous glucagon versus saline infusion (other)

Where the study takes place — 2 listed sites

Texas Diabetes Institute - University Health System
San Antonio, Texas, United States
Site recruitment: Recruiting
University of Texas San Antonio
San Antonio, Texas, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression

ClinicalTrials.gov · NCT07816744 · Registry updated: 2026-10-05

Condition / research focus: Atrial Fibrillation (AF); Obesity & Overweight
Sponsor: Axel Brandes
Countries with listed sites: Denmark
Registry dates and results: Start: 2026-10-01. Completion: 2030-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Structured weight loss program including behavioral support and optional meal re-placement or pharmacotherapy with Glucagon-like peptide-1 receptor agonists (GLP1-RA) (other)
Standard Care (in control arm) (other)

Where the study takes place — 2 listed sites

University Hospital Bispebjerg and Frederiksberg
Copenhagen, Denmark
Site recruitment: Not reported
Esbjerg Hospital - University Hospital of Southern Denmark
Esbjerg, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Active, not recruitingINTERVENTIONAL

GLP-1s to Enhance Lasting Optimal Weight

ClinicalTrials.gov · NCT06861439 · Registry updated: 2026-10-02

Condition / research focus: Obesity
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2025-07-07. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: Zepbound

Where the study takes place — 1 listed sites

Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

Tirzepatide in Obesity-Driven Endometrial Cancer

ClinicalTrials.gov · NCT07065552 · Registry updated: 2026-10-02

Condition / research focus: Endometrial Cancer; Obesity
Sponsor: UNC Lineberger Comprehensive Cancer Center
Countries with listed sites: United States
Registry dates and results: Start: 2026-04-27. Completion: 2028-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)

Where the study takes place — 1 listed sites

Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3Not yet recruitingINTERVENTIONAL

Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial

ClinicalTrials.gov · NCT07734792 · Registry updated: 2026-10-01

Condition / research focus: Acute Ischemic Stroke (AIS)
Sponsor: yifang zhu
Countries with listed sites: China
Registry dates and results: Start: 2026-09-20. Completion: 2028-07-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug) — also listed as: Mounjaro
Standard Medical Care (SMC) (other)

Where the study takes place — 1 listed sites

The Second Afliated Hospital of SooChow University
Suzhou, Jiangsu, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1RecruitingINTERVENTIONAL

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

ClinicalTrials.gov · NCT07793929 · Registry updated: 2026-10-01

Condition / research focus: End Stage Renal Disease; Renal Impairment; Obesity; Overweight
Sponsor: Kailera
Countries with listed sites: United States
Registry dates and results: Start: 2026-09-08. Completion: 2028-02-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ribupatide (drug) — also listed as: KAI-9531

Where the study takes place — 2 listed sites

Kailera Clinical Site
Orlando, Florida, United States
Site recruitment: Recruiting
Kailera Clinical Site
San Antonio, Texas, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2Active, not recruitingINTERVENTIONAL

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

ClinicalTrials.gov · NCT05254314 · Registry updated: 2026-10-01

Condition / research focus: Asthma
Sponsor: Vanderbilt University Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2022-10-11. Completion: 2026-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Semaglutide Pen Injector 2.4mg weekly (drug) — also listed as: Wegovy
Placebo (other)

Where the study takes place — 1 listed sites

Vanderbilt University Medical Center
Nashville, Tennessee, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Combination Therapy for Alcohol Use Disorder

ClinicalTrials.gov · NCT07249554 · Registry updated: 2026-10-01

Condition / research focus: Alcohol Use Disorder
Sponsor: Johns Hopkins University
Countries with listed sites: United States
Registry dates and results: Start: 2026-11. Completion: 2028-09 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug)
Glucagon-Like Peptide-1 Agonist (GLP-1) (drug)
Naltrexone (oral tablets) (drug)

Where the study takes place — 1 listed sites

Ashley Addiction Treatment
Havre de Grace, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Active, not recruitingINTERVENTIONAL

Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

ClinicalTrials.gov · NCT06854614 · Registry updated: 2026-09-30

Condition / research focus: Obesity
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2025-03-01. Completion: 2028-04-28 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Comprehensive weight loss (other)
Enhanced lifestyle changes (other)
Tirzepatide (drug) — also listed as: Mounjaro
Naltrexone-Bupropion (drug) — also listed as: Contrave
Phentermine-Topiramate (drug) — also listed as: Qsymia
Semaglutide (Wegovy®) (drug)

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

ClinicalTrials.gov · NCT06603571 · Registry updated: 2026-09-29

Condition / research focus: Obesity; Overweight
Sponsor: Eli Lilly and Company
Countries with listed sites: Argentina · United States
Registry dates and results: Start: 2024-09-20. Completion: 2026-09-14 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LY3841136 (drug)
Tirzepatide (drug)
Placebo (drug)

Where the study takes place — 52 listed sites

The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Chandler, Arizona, United States
Site recruitment: Not reported
HOPE Research Institute
Phoenix, Arizona, United States
Site recruitment: Not reported
Headlands Research - Scottsdale
Scottsdale, Arizona, United States
Site recruitment: Not reported
The Institute for Liver Health II dba Arizona Liver Health-Tucson
Tucson, Arizona, United States
Site recruitment: Not reported
NorCal Medical Research, Inc
Greenbrae, California, United States
Site recruitment: Not reported
Velocity Clinical Research, Huntington Park
Huntington Park, California, United States
Site recruitment: Not reported
Peninsula Research Associates
Rolling Hills Estates, California, United States
Site recruitment: Not reported
Diablo Clinical Research, Inc.
Walnut Creek, California, United States
Site recruitment: Not reported
Stamford Therapeutics Consortium
Stamford, Connecticut, United States
Site recruitment: Not reported
Northeast Research Institute (NERI)
Fleming Island, Florida, United States
Site recruitment: Not reported
Indago Research & Health Center, Inc
Hialeah, Florida, United States
Site recruitment: Not reported
New Horizon Research Center
Miami, Florida, United States
Site recruitment: Not reported
Suncoast Clinical Research, Inc.
New Port Richey, Florida, United States
Site recruitment: Not reported
Charter Research - Winter Park
Orlando, Florida, United States
Site recruitment: Not reported
Charter Research - Lady Lake
The Villages, Florida, United States
Site recruitment: Not reported
Medical Research Partners
Ammon, Idaho, United States
Site recruitment: Not reported
Great Lakes Clinical Trials - Andersonville
Chicago, Illinois, United States
Site recruitment: Not reported
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois, United States
Site recruitment: Not reported
NorthShore University Health System
Skokie, Illinois, United States
Site recruitment: Not reported
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, United States
Site recruitment: Not reported
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas, United States
Site recruitment: Not reported
Knownwell
Needham, Massachusetts, United States
Site recruitment: Not reported
Lucida Clinical Trials
New Bedford, Massachusetts, United States
Site recruitment: Not reported
Headlands Research - Detroit
Southfield, Michigan, United States
Site recruitment: Not reported
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan, United States
Site recruitment: Not reported
StudyMetrix Research
City of Saint Peters, Missouri, United States
Site recruitment: Not reported
Clinvest Headlands Llc
Springfield, Missouri, United States
Site recruitment: Not reported
Las Vegas Medical Research
Las Vegas, Nevada, United States
Site recruitment: Not reported
Dent Neurologic Institute
Amherst, New York, United States
Site recruitment: Not reported
Velocity Clinical Research, Syracuse
East Syracuse, New York, United States
Site recruitment: Not reported
North Suffolk Neurology
Port Jefferson Station, New York, United States
Site recruitment: Not reported
Rochester Clinical Research, LLC
Rochester, New York, United States
Site recruitment: Not reported
Medication Management
Greensboro, North Carolina, United States
Site recruitment: Not reported
Monroe Biomedical Research
Monroe, North Carolina, United States
Site recruitment: Not reported
Lucas Research, Inc
Morehead City, North Carolina, United States
Site recruitment: Not reported
Lucas Research, Inc.
New Bern, North Carolina, United States
Site recruitment: Not reported
CTI Clinical Research Center
Cincinnati, Ohio, United States
Site recruitment: Not reported
Tribe Clinical Research, LLC
Greenville, South Carolina, United States
Site recruitment: Not reported
Quality Medical Research
Nashville, Tennessee, United States
Site recruitment: Not reported
IMA Clinical Research Austin
Austin, Texas, United States
Site recruitment: Not reported
Velocity Clinical Research, Dallas
Dallas, Texas, United States
Site recruitment: Not reported
FutureSearch Trials of Dallas
Dallas, Texas, United States
Site recruitment: Not reported
PlanIt Research, PLLC
Houston, Texas, United States
Site recruitment: Not reported
Tekton Research - Fredericksburg Road
San Antonio, Texas, United States
Site recruitment: Not reported
Endeavor Clinical Trials
San Antonio, Texas, United States
Site recruitment: Not reported
Texas Valley Clinical Research
Weslaco, Texas, United States
Site recruitment: Not reported
Spectrum Medical, Inc.
Danville, Virginia, United States
Site recruitment: Not reported
Central Washington Health Services Association d/b/a Confluence Health
Wenatchee, Washington, United States
Site recruitment: Not reported
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, Argentina
Site recruitment: Not reported
Centro Médico Viamonte
Buenos Aires, Argentina
Site recruitment: Not reported
Consultorio de Investigación Clínica EMO SRL
Buenos Aires, Argentina
Site recruitment: Not reported
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, Argentina
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study

ClinicalTrials.gov · NCT07846956 · Registry updated: 2026-09-29

Condition / research focus: Non-arteritic Anterior Ischemic Optic Neuropathy Obesity; Obesity
Sponsor: Istanbul Saglik Bilimleri University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2026-09-21. Completion: 2026-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GLP-1 Receptor Agonist Therapy (drug)

Where the study takes place — 1 listed sites

Kanuni Sultan Süleyman Training and Research Hospital
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

ClinicalTrials.gov · NCT07527910 · Registry updated: 2026-09-29

Condition / research focus: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sponsor: Regeneron Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2026-05-22. Completion: 2030-03-15 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ALN-PNP (drug)
Tirzepatide (drug) — also listed as: Zepbound®
Placebo (drug)

Where the study takes place — 9 listed sites

Arizona Liver Health - Tucson
Tucson, Arizona, United States
Site recruitment: Recruiting
Southern California Research Center
Coronado, California, United States
Site recruitment: Recruiting
California Liver Research Institute
Pasadena, California, United States
Site recruitment: Recruiting
Health Awareness, Inc
Jupiter, Florida, United States
Site recruitment: Recruiting
Evolution Clinical Trials
Miami, Florida, United States
Site recruitment: Recruiting
Tandem Clinical Research, Plaza II
Metairie, Louisiana, United States
Site recruitment: Recruiting
American Research Corporation
Austin, Texas, United States
Site recruitment: Recruiting
Advanced Medical Trials
Georgetown, Texas, United States
Site recruitment: Recruiting
American Research Corporation at The Texas Liver Institute
San Antonio, Texas, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

ClinicalTrials.gov · NCT07078838 · Registry updated: 2026-09-28

Condition / research focus: Endometrial Cancer; Endometrial Intraepithelial Neoplasia; Grade 1 Endometrial Endometrioid Carcinoma
Sponsor: UNC Lineberger Comprehensive Cancer Center
Countries with listed sites: United States
Registry dates and results: Start: 2027-01. Completion: 2029-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tirzepatide (drug)

Where the study takes place — 1 listed sites

Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →